
Abstract Escherichia coli is widely used to produce recombinant proteins. For soluble overexpression, fusion technology has been developed using different fusion partners. In the present work, we used a newly developed nanoluciferase (NanoLuc) as a novel fusion partner for soluble overexpression of the aggregation-prone interleukin-6 (IL6). Soluble 6×His-NanoLuc-IL6 fusion protein was efficiently overexpressed in E. coli at a yield of approximately 60 mg per liter of culture broth after purification. The fusion partner was removed by enterokinase digestion and monomeric mature IL6 was obtained at a final yield of approximately 15 mg per liter of culture broth. The recombinant IL6 protein was fully active in the receptor activation assay, with a measured EC50 value of 117 ± 10 pM (n = 3). Thus, the novel NanoLuc-fusion approach was efficient for the soluble overexpression of active IL6 protein in E. coli and could be applied to other aggregation-prone proteins in future studies.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
